Two decades of risk factors and transfusion-transmissible infections in Dutch blood donors

Transfusion

Volumn 56, Issue 1, 2016, Pages 203-214

  Slot, Ed ^a   Janssen, Mart P ^a   Marijt Van Der Kreek, Tanneke ^b   Zaaijer, Hans L ^a,c   Van De Laar, Thijs J ^a,d  

^a CENTRAL LABORATORY   (Netherlands)

^b Division Research   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BLOOD DONOR; BLOOD SAFETY; DELTARETROVIRUS INFECTIONS; DONOR SELECTION; FEMALE; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMAN; INCIDENCE; MALE; MIDDLE AGED; NETHERLANDS; PREVALENCE; PROCEDURES; RISK FACTOR; STATISTICS AND NUMERICAL DATA; SYPHILIS; TRANSMISSION; VIRUS DISEASES;

ADULT; BLOOD DONORS; BLOOD SAFETY; DELTARETROVIRUS INFECTIONS; DONOR SELECTION; FEMALE; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NETHERLANDS; PREVALENCE; RISK FACTORS; SYPHILIS; VIRUS DISEASES;

EID: 84954400195     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13298     Document Type: Article

References (45)

1. Roth WK, Busch MP, Schuller A, et al., International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009. Vox Sang 2012; 102: 82-90.
2. Kleinman SH, Lelie N, Busch MP., Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion. Transfusion 2009; 49: 2454-88.
3. Lucky TT, Seed CR, Waller D, et al., Understanding non-compliance with selective donor deferral criteria for high-risk behaviors in Australian blood donors. Transfusion 2014; 54: 1739-49.
4. O'Brien SF, Xi G, Yi QL, et al., Understanding non-disclosure of deferrable risk: a study of blood donors with a history of intravenous drug use. Transfus Med 2010; 20: 15-21.
5. Blatyta PF, Custer B, Gonçalez, et al., Undisclosed human immunodeficiency virus risk factors identified through a computer-based questionnaire program among blood donors in Brazil. Transfusion 2013; 53: 2734-43.
6. Wilson K, Atkinson K, Keelan J., Three decades of MSM donor deferral policies. What have we learned? Int J Infect Dis 2014; 18: 1-3.
7. Offergeld R, Kamp C, Heiden M, et al., Sexual risk behaviour and donor deferral in Europe. Vox Sang 2014; 107: 420-7.
8. Belanger GA, McFarland W, Fisher R, et al., If the permanent deferral were lifted would men who have sex with men want to donate blood, and if so, who would be eligible? Transfusion 2013; 53: 2729-33.
9. van der Bij AK, Coutinho RA, van der Poel CL., Surveillance of risk-profiles among new and repeat blood donors with transfusion-transmissible infections from 1995 through 2003 in the Netherlands. Transfusion 2006; 46: 1729-36.
10. Lieshout-Krikke RW, Zaaijer HL, van de Laar TJ., Predonation screening of candidate donors and prevention of window period donations. Transfusion 2015; 55: 373-8.
11. Janssen MP, Cator EA, van der Poel CL, et al., Monitoring viral incidence rates: tool for the implementation of European union regulations. Vox Sang 2009; 96: 298-308.
12. Report on the global AIDS epidemic 2010 [Internet]. Geneva: UNAIDS; 2010 [cited 2015 Jun 9]. Available from: http://www.unaids.org/globalreport//Global-report.htm
13. Ott JJ, Stevens GA, Groeger J, et al., Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 2012; 30: 2212-9.
14. Gower E, Estes CC, Blach S, et al., Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol 2014; 61: S45-57.
15. Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, et al., Global epidemiology of HTLV-I infection and associated diseases. Oncogene 2005; 24: 6058-68.
16. Lucky TT, Seed CR, Keller A, et al., Trends in transfusion-transmissible infections among Australian blood donors from 2005-2010. Transfusion 2013; 53: 2751-62.
17. Safe supplies: completing the picture. Annual review from the NHS Blood and Transplant/HPE Epidemiology Unit, 2012 [Internet]. London: NHS Blood and Transplant/Public Health England; 2013 Sep [cited 2015 Jun 9]. Available from: http://webarchive.nationalarchives.gov.uk/20140714084352/http:/www.hpa.org.uk/webc/HPAwebFile/HPAweb-C/1317139826539
18. Offergeld R, Ritter S, Hamouda O., [ HIV, HCV, HBV and syphilis surveillance among blood donors in Germany 2008-2010]. Bundesgesundheidsblaat Gesundheidsforschung Gesundheidsschutz 2012; 55: 907-13. German.
19. Custer B, Kessler D, Vahidnia F, et al., Risk factors for retrovirus and hepatitis virus infections in accepted blood donors. Transfusion 2015; 55: 1098-107.
20. Surveillance report 2014 [Internet]. Ottawa: Canadian Blood Services; 2014 [cited 2015 Jun 9]. Available from: https://www.blood.ca/sites/default/files/blood/blood-safety/External-Surveillance-Report-2014.pdf
21. Janssen MP, Behr-Gross ME., Trends and observations on the collection, testing and use of blood and blood components in Europe. 2001-2008 report [Internet]. Strasbourg: European Directorate for the Quality of Medicines and HealthCare; 2014 [cited 2015 Jun 9]. Available from: https://www.edqm.eu/medias/fichiers/trends-and-observations-on-the-collection-testing-and-use-of-blood-and-blood-components-in-europe.pdf
22. Delwart E, Slikas E, Stramer SL, et al., Genetic diversity of recently acquired and prevalent HIV, hepatitis B virus, and hepatitis C virus in US blood donors. J Infect Dis 2012; 205: 875-85.
23. Monitoring report 2014: human immunodeficiency virus (HIV) in the Netherlands [Internet]. Amsterdam: Dutch HIV-monitoring Foundation; 2014 [cited 2015 Jun 9]. Available from: http://www.hiv-monitoring.nl/files/8914/1527/1076/SHM-Monitoring-report-2014.pdf
24. Hahné SJ, de Melker HE, Kretzschmar M, et al., Prevalence of hepatitis B virus infection in the Netherlands in 1996 and 2007. Epidemiol Infect 2012; 140: 1469-80.
25. Vriend HJ, Op de Coul EL, van de Laar TJ, et al., Hepatitis C virus seroprevalence in the Netherlands. Eur J Pub Health 2012; 22: 819-21.
26. de Vos AS, van der Helm JJ, Matser A, et al., Decline in the incidence of HIV and hepatitis C virus infection among injecting drug users in Amsterdam: evidence for harm reduction? Addiction 2013; 108: 1070-81.
27. Gane E, Kershenobich D, Sequin-Devaux C, et al., Strategies to manage hepatitis C virus (HCV) infection disease burden- volume 2. J Viral Hepat 2015; 22: 46-73.
28. O'Brien SF, Fan W, Xi G, et al., Declining hepatitis C rates in first-time blood donors: insight from surveillance and case-control risk factor studies. Transfusion 2008; 48: 902-9.
29. Terrault NA, Dodge JL, Murphy EL, et al., Sexual transmission of HCV among monogamous heterosexual couples: the HCV partners study. Hepatology 2013; 57: 881-9.
30. Paez-Jimenez A, Sharaf-Eldin N, Rimlinger F, et al., HCV iatrogenic and intrafamilial transmission in Greater Cairo, Egypt. Gut 2010; 59: 1554-60.
31. Rosenberg GK, Lattimore S, Brailsford SR, et al., The diversity of chronic hepatitis B virus infections within blood donors in England and North Wales 2005 through 2010. Transfusion 2013; 53: 2467-76.
32. O'Brien SF, Xi G, Fan W, et al., Epidemiology of hepatitis B in Canadian blood donors. Transfusion 2008; 48: 2323-30.
33. O'Brien SF, Goldman M, Scalia V, et al., The epidemiology of human T-cell lymphotropic virus types I and II in Canadian blood donors. Transfus Med 2013; 23: 358-66.
34. Whelan J, Sonder G, Heuker J, et al., Incidence of acute hepatitis B in different ethnic groups in a low endemic country, 1992-2009: increased risk in second generation migrants. Vaccine 2012; 30: 5651-5.
35. van Rijckevorsel G, Whelan J, Kretzschmar M, et al., Targeted vaccination programme successful in reducing acute hepatitis B in men having sex with men in Amsterdam, the Netherlands. J Hepatol 2013; 59: 1177-83.
36. Read P, Fairley CK, Chow EP., Increasing trends of syphilis in men who have sex with men in high-income countries. Sex Health 2015 [Epub ahead of print].
37. van Aar F, Koedijk FD, van den Broek IV, et al., Sexually transmitted infections, including HIV, in the Netherlands in 2013 [Internet]. RIVM report number 150002005/2014. Bilthoven: National Institute for Public Health and Environment; 2014 [cited 2015 June 9]. Available from: http://www.rivm.nl/dsresource?objectid=rivmp:262211&type=org& disposition=inline
38. Seed C, Kiely P, Law M, et al., No evidence of a significantly increased risk of transfusion-transmitted human immunodeficiency virus infection in Australia subsequent to implementing a 12-month deferral of men who have sex with men (CME). Transfusion 2010; 50: 2722-30.
39. De Buck E, Dieltjens T, Compernolle V, et al., Is having sex with other men a risk factor for transfusion-transmissible infections in male blood donors in western countries? A systematic review. PLoS One 2015; 10: e0122523.
40. Grenfell P, Nutland W, McManus S, et al., Views and experiences of men who have sex with men on the ban of blood donation: a cross-sectional survey with qualitative interviews. BMJ 2011; 343: d5604.
41. Wilkinson SL, Vij V, Steele WR,; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II). Donors' perspectives on their postdonation information (PDI) event: a qualitative interview study of PDI donors. Transfusion 2012; 52: 1062-9.
42. Soetens LC, van Benthem BH, Urbanus A, et al., Ongoing transmission of hepatitis B virus in rural parts of the Netherlands, 2009-2013. PLoS One 2015; 10: e0117703.
43. van de Laar TJ, Koppelman MH, van der Bij AK, et al., Diversity and origin of hepatitis C virus among unpaid blood donors in the Netherlands. Transfusion 2006; 46: 1719-28.
44. Bezemer D, van Sighem A, Lukashov VV, et al., Transmission networks of HIV-1 among men having sex with men in the Netherlands. AIDS 2010; 24: 271-82.
45. Urbanus AT, van den Hoek A, Boonstra A, et al., People with multiple tattoos and/or piercings are not at increased risk for HBV and HCV in the Netherlands. PLoS One 2011; 6: e0024736.